Scribe Therapeutics Inc.
SCTX
IPO
$29.41
-$1.93-6.16%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.52% | -- | |||
| Total Receivables | -19.07% | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -24.59% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | -13.92% | -- | |||
|
|
|||||
| Total Current Assets | -13.92% | -- | |||
| Net Property, Plant & Equipment | -8.36% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 22.67% | -- | |||
| Total Assets | -11.17% | -- | |||
|
|
|||||
| Total Accounts Payable | -45.88% | -- | |||
| Total Accrued Expenses | 70.99% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -6.46% | -- | |||
| Total Finance Division Other Current Liabilities | 3.37% | -- | |||
| Total Other Current Liabilities | 3.37% | -- | |||
| Total Current Liabilities | -1.28% | -- | |||
|
|
|||||
| Total Current Liabilities | -1.28% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -8.01% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 1.07% | -- | |||
| Total Liabilities | -1.13% | -- | |||
|
|
|||||
| Common Stock & APIC | 2.27% | -- | |||
| Retained Earnings | -3.70% | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | -3.85% | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 0.00% | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 0.00% | -- | |||
|
|
|||||
| Total Common Equity | -3.85% | -- | |||
| Total Preferred Equity | 0.00% | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -15.91% | -- | |||
|
|
|||||